PRAME and melanoma: While PRAME (preferentially expressed antigen on melanomas) shows only minute expression in healthy tissues, high expression was found in diverse cancers like acute or chronic lymphoblastic or myeloid leukemia, making it an interesting target for T cell-based therapy [38].